165 results
Page 6 of 9
6-K
EX-99
cip2enn 2fz2tu113aa6
5 Aug 13
BioLineRx Announces Publication of Positive
12:00am
6-K
EX-99
1sg2dyc8449n72uto05
29 Jul 13
BioLineRx Announces CE-Mark Registration
12:00am
6-K
EX-99
ke4c34
10 Jun 13
Current report (foreign)
12:00am
6-K
EX-99
ngf785x9hu3h
6 Jun 13
Current report (foreign)
12:00am
6-K
EX-99.1
wgnc9lz
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
6-K
EX-10.1
dikhcq0oe g075uoyjw5
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B5
m46u ohy3cd
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
k1musitx3 son1z6ztf
17 May 13
Prospectus supplement for primary offering
12:00am
6-K
EX-99
1cxa04eptu 2pwwgc9rh
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
6-K
EX-99
osr r5orkpw75zebbuj8
29 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
ghm8exbsq07lcuiz
17 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
y96q4a
10 Apr 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
6-K
EX-99
dr7c9 au8san
20 Mar 13
BioLineRx Announces Results from Interim Analysis of
12:00am
6-K
EX-99
w5pon i0d
13 Mar 13
BioLineRx Receives Approval from French Regulatory
12:00am
6-K
EX-99
l9k98eg
12 Mar 13
BioLineRx Reports Year End 2012 Financial Results
12:00am
6-K
EX-99
0e0 kuv4xyrbm
28 Feb 13
Current report (foreign)
12:00am
6-K
EX-99.1
do2yaqg8
13 Feb 13
BioLineRx Announces Closing of $8 Million Offering of American
12:00am
424B5
cmas22w50
6 Feb 13
Prospectus supplement for primary offering
12:00am
6-K
EX-99
kesl6kso
4 Feb 13
Current report (foreign)
12:00am